🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesNNT for MACE prevention — 6 month update Page 3

NNT for MACE prevention — 6 month update

MikeNYC_runner Mon, Aug 25, 2025 at 1:57 AM 12 replies 1,433 viewsPage 3 of 3
AussieAnna
Member
678
2,890
Jun 2024
Sydney, AU
Aug 25, 2025 at 6:12 AM#11

LibrarianMeg — wow. This community is amazing.

29 14TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 26 others
Reply Quote Save Share Report
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Aug 25, 2025 at 6:29 AM#12

Slightly tangential to NNT for MACE prevention but MikeNYC_runner reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

20 7Dr.PathRoch, mona_PHX, andrew_nyc and 17 others
Reply Quote Save Share Report
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Aug 25, 2025 at 6:46 AM#13

Thanks for sharing this, MikeNYC_runner. A few questions about your NNT for MACE experience:

  1. What dose are you currently on?
  2. How long before you noticed significant changes?
  3. Did your doctor have any specific recommendations about NNT for MACE?

I am in a similar boat and trying to learn from others' experiences before my next appointment.

6 7LabKate, kate.chem, DataDave and 3 others
Reply Quote Save Share Report
MikeNYC_runner
Member
378
1,678
Jul 2024
New York, NY
Aug 25, 2025 at 7:03 AM#14

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on NNT for MACE prevention .

To answer jason_paloalto: yes, I am on compounded sema from a 503B pharmacy.

Quick update: things are still going well. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

Last edited: Aug 25, 2025 at 9:03 AM
45 1GenomicsKate, Dr.ObesityMed, HealthEcon_DC and 42 others
Reply Quote Save Share Report
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Aug 25, 2025 at 7:20 AM#15

Relevant to NNT for MACE prevention 6 — here is my latest bloodwork comparison:

Key improvements: A1C 7.6% → 5.5%, triglycerides 201 → 101 mg/dL, hsCRP 8.0 → 1.3 mg/L. All on tirzepatide for 17 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Last edited: Aug 25, 2025 at 9:20 AM
50 8pete_manc_UK, anna.melb_AU, mark_tokyo and 47 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register